UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028168
Receipt number R000032110
Scientific Title Study of safety and efficacy of Endoscopic Ultrasonography with Jelly injection
Date of disclosure of the study information 2017/07/14
Last modified on 2019/07/12 11:37:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of safety and efficacy of Endoscopic Ultrasonography with Jelly injection

Acronym

USJ Study

Scientific Title

Study of safety and efficacy of Endoscopic Ultrasonography with Jelly injection

Scientific Title:Acronym

USJ Study

Region

Japan


Condition

Condition

Gastrointestinal tract tumor and esophagogastric varix

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Study on the safety and effectiveness of endoscopically injecting OS-1 jelly as a pretreatment for ultrasonic endoscopy for patients with or suspected of gastrointestinal tumor or esophageal varices .

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pre-treatment success rate of ultrasonic endoscopic examination

Key secondary outcomes

Serious adverse event


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

As a pretreatment for ultrasonic endoscope, inject up to 400 ml of OS-1 jelly in case of insufficient 5 minutes or 400 ml of water injection method.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Ultrasonic endoscopy with a probe method is planned with tumors of the esophagus, stomach, duodenum, small intestine, or large intestine, or with or suspected esophageal varices.

Key exclusion criteria

1) Cases with occlusion or high stenosis in the gastrointestinal tract.
2) Patients with a history of aspiration pneumonia or suspected of deteriorating swallowing function.
3) A case in which it is judged that the risk of endoscopic examination complicates gastrointestinal diseases such as intestinal perforation and acute pancreatitis and the effectiveness is exceeded.
4) Cases in which respiratory circulation status is not stable due to respiratory diseases, cardiovascular diseases, etc. and it is judged that it is difficult to perform endoscopic examination safely.
5) Other cases that the person in charge judged inappropriate to participate in this exam.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hajime Takatori

Organization

Kanazawa University Hospital

Division name

Gastroenterology

Zip code


Address

13-1,Takara-machi,Kanazawa

TEL

076-265-2235

Email

takatori@m-kanazawa.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takeshi Terashima

Organization

Kanazawa University Hospital

Division name

Gastroenterology

Zip code


Address

13-1,Takara-machi,Kanazawa

TEL

076-265-2235

Homepage URL


Email

hajimetakatori@gmail.com


Sponsor or person

Institute

Kanazawa University Hospital, Department of Gastroenterology

Institute

Department

Personal name



Funding Source

Organization

Kanazawa University Hospital, Department of Gastroenterology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 07 Day

Date of IRB

2017 Year 07 Month 14 Day

Anticipated trial start date

2017 Year 07 Month 10 Day

Last follow-up date

2018 Year 03 Month 08 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 07 Month 10 Day

Last modified on

2019 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032110


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name